Frontlight ResearchEarly access
Prostate cancer trials in United States
655 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleREGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
- Where
- Duarte, Goodyear, Houston, St Louis, Tampa, Zion
- Age
- 18 years and over
- People
- 265
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07594106 - No phaseNot yet taking people in United StatesCancer Oriented Understanding and Navigation Via Supportive and Educational Language Models (COUNSEL)
- Where
- San Francisco
- Age
- 18 years and over
- People
- 50
- Run by
- University of California, San Francisco
See details and how to joinNCT07836933 - No phaseEnrolling by invitationMR-Guided Cryoablation of Prostate Bed Recurrences
- Where
- Rochester
- Age
- 30 years to 100 years
- People
- 200
- Run by
- Mayo Clinic
See details and how to joinNCT01727284 - Phase 3Taking peopleScreening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- Where
- Dallas, Los Angeles
- Age
- 50 years to 70 years
- People
- 1,284 worldwide
- Run by
- University of Alberta
See details and how to joinNCT06626022 - Early phase 1Taking peoplePre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
- Where
- Houston
- Age
- 18 years and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06759701 - Phase 1Taking peoplePhase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Where
- Baltimore, Boston, La Jolla, Minneapolis, Myrtle Beach, Omaha, Seattle, Tampa
- Age
- 18 years and over
- People
- 88 worldwide
- Run by
- Acerand Therapeutics (Hong Kong) Limited
See details and how to joinNCT06801236 - No phaseTaking peopleDESTINY-PANTUMOUR04
- Where
- Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
- Age
- 18 years to 130 years
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07124000 - No phaseTaking peopleA Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
- Where
- Jacksonville
- People
- 200
- Run by
- Mayo Clinic
See details and how to joinNCT07126548 - Phase 1Taking peopleA Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- Where
- Dallas, Nashville, New Hyde Park, Philadelphia, Reunion
- Age
- 18 years and over
- People
- 83 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07277270 · EU 2025-522274-37-00 - No phaseTaking peopleDecision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 108
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07377006 - No phaseTaking peopleReduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
- Where
- Boston
- Age
- 18 years and over
- People
- 66
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07729150 - Phase 1Taking peopleA Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Where
- Atlanta, Hackensack, Portland
- Age
- 18 years and over
- People
- 36
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07543055 - Phase 1Taking peopleA Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- Where
- Boston, East Brunswick, Fort Worth, Grand Rapids, Houston, Los Angeles, Myrtle Beach, Nashville, San Antonio
- Age
- 18 years and over
- People
- 60
- Run by
- Flare Therapeutics Inc.
See details and how to joinNCT07719361 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Albuquerque, Boston, Cincinnati, Columbus, Commack, East Brunswick, Grand Rapids, Houston, Kansas City, Los Angeles, Madison, Muncie, Nashville, Portland, San Diego, Santa Rosa
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - No phaseTaking peoplePrecise Oncology Interventions in Nutrition and Training (OnPoint)
- Where
- Miami
- Age
- 18 years and over
- People
- 306
- Run by
- University of Miami
See details and how to joinNCT06534918 - Phase 2Taking peopleAndrogen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
- Where
- Scottsdale
- Age
- 18 years and over
- People
- 30
- Run by
- Mayo Clinic
See details and how to joinNCT07025369 - No phaseTaking peopleCV CARE: CardioVascular Care in PC Patients
- Where
- Boston
- Age
- 18 years and over
- People
- 180
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06202820 - Phase 2/3Taking peopleOpen-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Where
- Athens, Atlanta, Boston, Chicago, Dallas, Denver, Fairfax, Gahanna, Hartford, Indianapolis, Kansas City, Los Angeles, Metairie, Miami, Milwaukee, Murray, Myrtle Beach, New York, Omaha, Orlando, Palo Alto, Philadelphia, Roanoke, San Antonio, Santa Barbara, Santa Monica, Scottsdale, Seattle, Springfield, St Louis, Syracuse, The Bronx, Voorhees Township
- Age
- 18 years to 100 years
- People
- 443 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06780670 · EU 2024-512342-42-00 - Phase 1Taking peoplePhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Boston, Iowa City, Royal Oak, Seattle
- Age
- 18 years to 100 years
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - Phase 2Taking peoplePSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT
- Where
- Baltimore
- Age
- 18 years and over
- People
- 60
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07550517 - No phaseTaking peopleProtoacoustic Imaging For 3D Mapping
- Where
- Oklahoma City
- Age
- 18 years and over
- People
- 24
- Run by
- University of Oklahoma
See details and how to joinNCT07832617 - Phase 1Taking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Aurora, Beverly Hills, Boston, Chicago, Duarte, Fairfax, Greenville, Houston, Iowa City, Louisville, Miami, Nashville, New Haven, New York, Orange, Orlando, Port Saint Lucie, Santa Monica, Seattle, Washington D.C.
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - Phase 2Taking peoplePSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
- Where
- Omaha
- Age
- 30 years and over
- People
- 54
- Run by
- University of Nebraska
See details and how to joinNCT07234981 - Phase 2/3Taking peopleDose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
- Where
- Grand Rapids
- Age
- 18 years and over
- People
- 408
- Run by
- Lantheus Medical Imaging
See details and how to joinNCT07831824 - Phase 1/2Taking peoplePhase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
- Where
- Houston
- Age
- 18 years and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06085729